ABCG5 and fatty liver disease: In analyses of human and animal models, ABCG5/G8 have also been shown to affect various cardiometabolic traits and disorders, such as lipid and glucose metabolism, blood pressure control, metabolic syndrome, and fatty liver disease [23,24,25,26,27,28,29,30].